Your browser doesn't support javascript.
loading
Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.
O'Reilly, Michael W; Taylor, Angela E; Crabtree, Nicola J; Hughes, Beverly A; Capper, Farfia; Crowley, Rachel K; Stewart, Paul M; Tomlinson, Jeremy W; Arlt, Wiebke.
Afiliação
  • O'Reilly MW; Centre for Endocrinology, Diabetes, and Metabolism (M.W.O., A.E.T., B.A.H., R.K.C., P.M.S., J.W.T., W.A.), School of Clinical and Experimental Medicine, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom; Department of Nuclear Medicine (N.J.C.), University Hospitals Birmingham, Edgbaston, and National Institute of Health Research/Wellcome Trust Clinical Research Facility (F.C.), University Hospitals Birmingham National Health Service Foundation Trust, Birmingham B15 2TH, Uni
J Clin Endocrinol Metab ; 99(3): 1027-36, 2014 Mar.
Article em En | MEDLINE | ID: mdl-24423344

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndrome do Ovário Policístico / Hiperandrogenismo / Androstenodiona Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies Limite: Adult / Female / Humans Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndrome do Ovário Policístico / Hiperandrogenismo / Androstenodiona Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies Limite: Adult / Female / Humans Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2014 Tipo de documento: Article